Why HIV virions have low numbers of envelope spikes: implications for vaccine development. by John Schiller, Bryce Chackerian

Get full text

Superior Potency of Synthetic Virus-like Structures in Vaccine-Induced Antibody Responses Compared to Qβ Bacteriophage Virus-like Particles by Alexander R. Meyer, Libo Li, Wei-Yun Wholey, Bryce Chackerian, Wei Cheng

Get full text

Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses. by Kathryn M Frietze, Juan M Pascale, Brechla Moreno, Bryce Chackerian, David S Peabody

Get full text

Multi-phase Training in Virus-Like Particle Synthesis to Foster Science Self-efficacy in Students With Minimal Laboratory Experience by Macie Proctor-Roser, Marinca Faimau, Julianne Peabody, Krystal Charley, Bryce Chackerian, Naomi Lee

Get full text

pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model by Jonathan P. Hulse, Nicole M. Maphis, Julianne Peabody, Virginie Bondu, Bryce Chackerian, Kiran Bhaskar

Get full text

Virus-like particle vaccines targeting a key epitope in circumsporozoite protein provide sterilizing immunity against malaria by Yogesh Nepal, Alexandra Francian, Yevel Flores-Garcia, Bryce T. Roberts, Sunil A. David, Fidel Zavala, Bryce Chackerian

Get full text

Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses by Andre A Teixeira, Serena Marchiò, Emmanuel Dias‐Neto, Diana N Nunes, Israel T da Silva, Bryce Chackerian, Marc Barry, Richard C Lauer, Ricardo J Giordano, Richard L Sidman, Cosette M Wheeler, Webster K Cavenee, Renata Pasqualini, Wadih Arap

Get full text